Mercado Global de Análise de Epigenomas – Tendências da Indústria e Previsão para 2030

Análise de epigenoma Análise de mercado e tamanho

De acordo com o NCI, a taxa anual de mortalidade por cancro nos Estados Unidos é de 163,5 por 100.000 homens e mulheres. O Consórcio Internacional do Genoma do Cancro (ICGC) está a trabalhar para caracterizar a genómica do tumor, as alterações epigenómicas e as alterações transcriptómicas. Espera-se que o aumento da prevalência do cancro, das doenças crónicas e da crescente população geriátrica todos estes factores impulsionem o crescimento do mercado.

A Data Bridge Market Research analisa que o mercado de análise de epigenoma, que foi de 1,47 mil milhões de dólares em 2022, deverá atingir os 4,5 mil milhões de dólares até 2030, com um CAGR de 15% durante o período de previsão de 2023 a 2030. Para além dos insights sobre cenários de mercado como o valor de mercado, a taxa de crescimento, a segmentação, a cobertura geográfica e os grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research incluem também análises especializadas aprofundadas, epidemiologia de doentes, análise de pipeline, análise de preços e enquadramento regulamentar.

Âmbito e segmentação do mercado de análise de epigenoma      

Definição de mercado

A epigenética é o estudo das alterações na função genética que ocorrem sem quaisquer alterações na sequência do ADN. Vários estudos anteriores sugeriram que as alterações epigenéticas são hereditárias. Este subprojeto centra-se no mecanismo epigenético de metilação do ADN, que pode ser medido internamente utilizando o Infinium HumanMethylation450 BeadChip ou o nosso protocolo implementado de Sequenciação de Bissulfito de Representação Reduzida (RRBS) baseado em NGS. Estão disponíveis todas as ferramentas de bioinformática necessárias para detetar regiões diferencialmente metiladas em dados RRBS NGS.

Dinâmica global do mercado de análise de epigenomas

Motoristas

• Aumento das atividades de investigação e desenvolvimento

Organizações como o Consórcio Internacional de Epigenoma Humano (IHEC), o Instituto Nacional do Cancro (NCI) e o Instituto Nacional de Saúde (NIH) estão a influenciar o crescimento do mercado. Estas organizações defendem o financiamento e o apoio à investigação e desenvolvimento em epigenética. Os Institutos Nacionais de Saúde financiam a investigação epigenética através de um programa epigenómico de fundo comum, que apoia activamente novas investigações epigenéticas em todo o mundo. A crescente procura pela compreensão das modificações epigenéticas a nível molecular e pelo desenvolvimento de soluções terapêuticas irá provavelmente motivar estas organizações a financiar programas de investigação e desenvolvimento. Além disso, iniciativas como o Programa de Investigação em Epidemiologia e Genómica (EGRP) proporcionam incentivos para actividades de investigação destinadas a compreender melhor as causas e os resultados do cancro.

• Iniciativas Governamentais

O projeto Enciclopédia de Elementos de ADN (ENCODE) foi iniciado pelo Instituto Nacional de Investigação do Genoma Humano dos Estados Unidos com o objetivo de identificar todos os elementos funcionais da sequência do genoma humano. O Consórcio Internacional de Epigenoma Humano (IHEC), financiado pelo NIH, também está envolvido na geração e análise de dados epigenómicos que os investigadores epigenómicos podem utilizar. A maior parte da investigação epigenética visa identificar opções de tratamento para vários tipos de tumores.

Oportunidades

• Aumento da população geriátrica

A rise in the geriatric population is expected to boost market growth. According to WHO, the global population of people aged 65 and up is expected to grow from 1 billion in 2019 to approximately 1.4 billion by 2030 and 2.1 billion by 2050, with developing countries accounting for a significant increase. Aging is thought to be the greatest risk factor for cardiovascular and neurological diseases, so it is expected to increase the risk of developing these diseases. Furthermore, ageing weakens the immune system and increases the risk of contracting infectious diseases. Furthermore, the growing geriatric population in Asian countries such as China, Japan, and India, which have significant untapped potential, is expected to drive market growth during the forecast period.

Restraints/Challenges

• High R&D costs

High R&D costs for developing novel products and a stringent approval process are impeding market growth. Before being commercialized, the appropriate regulatory authorities must approve novel epigenetic drugs. This framework for drug approval is time-consuming and stringent. There are no clear regulatory policies in place in emerging economies such as China and India, where the diagnostic market has significant growth potential due to a large patient pool. However, a lack of skilled labour and insufficient health insurance coverage in remote areas are two major impediments to the growth of this market.

This epigenome analysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the epigenome analysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Epigenome Analysis Market

The Covid-19 pandemic had a significant impact on the epigenome analysis market growth. According to a study published in BioMed Central, epigenetic changes may play an important role in the emergence of coronavirus illness consequences. Although several epigenetic therapies are being investigated, more research is required to develop an effective vaccine and safer therapeutic options, including epigenetic treatments, to combat this viral pandemic. As a result, more epigenetics will be used in the identification of COVID-19 infection therapeutics, fueling market growth throughout the forecast period.

Epigenome Analysis Market Scope

The epigenome analysis market is segmented on the basis of technology, component, methods and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

• Elisa
• ChIP Qpcr
• ChIP‐on‐Chip
• Others

 Components

• Ethylation
• Acetylation
• Phosphorylation
• Ubiquitylation
• Sumoylation

 Methods

• DNA Methylation Analysis
• Analysis of DNA/Protein Interactions
• Chromatin Accessibility
• Conformation Assays

 End Users

• Academic and Research Institutes
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations

Epigenome Analysis Market Regional Analysis/Insights

The epigenome analysis market is analyzed and market size insights and trends are provided by country, technology, component, methods and end users as referenced above.

The countries covered in the epigenome analysis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the epigenome analysis market because of the availability of advanced healthcare facilities and continual advancements in diagnostic procedures.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the rise in the disposable income. Moreover, the growing untapped clinical needs of the patients is further anticipated to grow in the region's epigenetics market in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The epigenome analysis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for epigenome analysis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the epigenome analysis market. The data is available for historic period 2011-2021.

Competitive Landscape and Epigenome Analysis Market Share Analysis

The epigenome analysis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to epigenome analysis market.

Some of the major players operating in the epigenome analysis market are:

• Illumina, Inc. (U.S.)
• Merck KGaA (Germany)
• QIAGEN (Germany)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Eisai Co., Ltd. (Japan)
• Novartis AG (Switzerland)
• Abcam plc (U.K.)
• Diagenode s.a. (U.S.)
• Active Motif, Inc. (U.S.)
• Zymo Research Corporation. (U.S.)
• Thermo Fisher Scientific (U.S.)
• Cellcentric (Germany)
• Syndax (U.S.)
• New England Biolabs (U.S.)
• Epizyme, Inc. (U.S.)
• Domainex (U.K.)
• Agilent Technologies, Inc. (U.S.)
• PerkinElmer Inc. (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• AsisChem Inc. (U.S.)
• Enzo Life Sciences, Inc. (U.S.)
• EpiGentek Group Inc. (U.S.)
• BioVision Inc. (U.S.)
• Bio-Techne. (U.S.)
• Promega Corporation (U.S.)
• GeneTex, Inc. (U.S.)
• Pacific Biosciences of California, Inc. (U.S.)

Research Methodology: Global Epigenome Analysis Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (Factbook) ou pode ajudá-lo na criação de apresentações a partir dos conjuntos de dados disponíveis no relatório.

SKU-56458